Choksi Laboratories Quarterly Results
Choksi Laboratories quarterly results. In 2026, Choksi Laboratories (CHOKSILA) reported revenue ₹48 Cr and net profit ₹2 Cr. Check Choksi Laboratories market cap to track the company's total market size over time.
CHOKSILA Quarterly Results — Revenue, Profit & EPS Highlights
Choksi Laboratories latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Review CHOKSILA P/E ratio to evaluate earnings-based valuation against sector peers.
- Revenue of ₹46 Cr in March 2026 (+0.0% vs March 2026, +9.5% vs March 2025)
- Net Profit of ₹2 Cr in March 2026 (+0.0% vs March 2026, +0.0% vs March 2025)
- EBITDA of ₹12 Cr in March 2026 (+0.0% vs March 2026)
- Operating Margin of 26.0% in March 2026 (+0.0pp vs March 2026)
- Earnings Per Share of ₹2.82 in March 2026 (+0.0% vs March 2026)
Choksi Laboratories Quarterly Results — Revenue, EBITDA, Net Profit & EPS
CHOKSILA quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.
| Metric | 2026 | March 2026 | March 2025 | March 2024 | March 2023 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 48 | 46 | 42 | 37 | 35 | 4.3% | - |
| Net Profit (₹ Cr) | 2 | 2 | 2 | 1 | 3 | - | - |
| EBITDA (₹ Cr) | 13 | 12 | 11 | 10 | 11 | - | - |
| EPS (₹) | 3.10 | 2.82 | 2.19 | 1.59 | 4.61 | - | - |
| Operating Margin (%) | 27.0% | 26.0% | 27.0% | 28.0% | 30.0% | - | - |
CHOKSILA Share Price Trend — 1-Year Movement Across Quarterly Results
Choksi Laboratories 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. For annual financials, live price and key ratios, visit Choksi Laboratories share price today.
Revenue Trend (₹ Cr)
Net Profit Trend (₹ Cr)
Operating Margin Trend (%)
CHOKSILA vs Healthcare Services Peers — Quarterly Revenue, Profit & Market Cap
Choksi Laboratories latest quarter revenue and net profit vs Healthcare Services competitors — market cap, price and earnings comparison.
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Apollo Hospitals
Mar 2026 |
₹109,341.00 Cr | 7604.5 | 6,660 | 551 | -6.3% | - | 8.3% | 206.5 |
|
Max Healthcare Inst…
Mar 2026 |
₹80,784.75 Cr | 817.0 | 2,191 | 342 | -9.0% | - | 15.6% | 232.1 |
|
Fortis Healthcare
Mar 2026 |
₹55,700.81 Cr | 726.7 | 2,375 | 271 | -7.7% | - | 11.4% | 206.4 |
|
Aster DM Healthcare
Mar 2026 |
₹42,146.56 Cr | 654.7 | 1,219 | 154 | -0.6% | +18.1% | 12.6% | 240.7 |
|
Narayana Hrudayalaya
Mar 2026 |
₹35,577.17 Cr | 1693.2 | 2,623 | 224 | -3.5% | - | 8.5% | 153.6 |
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores